1. Home
  2. Labeler Index
  3. Xiromed Llc
  4. 70700-264
  5. NDC Package Code: 70700-264-22 Glycopyrrolate 1ml

NDC Package 70700-264-22 Glycopyrrolate 1ml

Glycopyrrolate Injection Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70700-264-22
Package Description:
1 VIAL in 1 CARTON / 1 mL in 1 VIAL
Product Code:
70700-264
Proprietary Name:
Glycopyrrolate 1ml
Non-Proprietary Name:
Glycopyrrolate
Substance Name:
Glycopyrrolate
Usage Information:
Glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This medication works by decreasing the amount of saliva you make. Glycopyrrolate belongs to a class of drugs known as anticholinergics.
11-Digit NDC Billing Format:
70700026422
NDC to RxNorm Crosswalk:
  • RxCUI: 1731582 - glycopyrrolate 0.2 MG in 1 ML Injection
  • RxCUI: 1731582 - 1 ML glycopyrrolate 0.2 MG/ML Injection
  • RxCUI: 1731582 - glycopyrrolate 0.2 MG per 1 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Xiromed Llc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • GLYCOPYRROLATE .2 mg/mL
    • Pharmacologic Class(es):
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA212227
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-03-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70700-264-22?

    The NDC Packaged Code 70700-264-22 is assigned to a package of 1 vial in 1 carton / 1 ml in 1 vial of Glycopyrrolate 1ml, a human prescription drug labeled by Xiromed Llc. The product's dosage form is injection and is administered via intramuscular; intravenous form.

    Is NDC 70700-264 included in the NDC Directory?

    Yes, Glycopyrrolate 1ml with product code 70700-264 is active and included in the NDC Directory. The product was first marketed by Xiromed Llc on August 03, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70700-264-22?

    The 11-digit format is 70700026422. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270700-264-225-4-270700-0264-22